Cardiff Oncology Inc (CRDF)
3.64
-0.10
(-2.67%)
USD |
NASDAQ |
May 17, 16:00
3.64
0.00 (0.00%)
After-Hours: 20:00
Cardiff Oncology Cash from Investing (Quarterly): 4.636M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.636M |
| December 31, 2023 | 13.56M |
| September 30, 2023 | 3.821M |
| June 30, 2023 | 11.48M |
| March 31, 2023 | 7.329M |
| December 31, 2022 | 7.02M |
| September 30, 2022 | 5.163M |
| June 30, 2022 | 7.608M |
| March 31, 2022 | 18.36M |
| December 31, 2021 | -8.794M |
| September 30, 2021 | 8.049M |
| June 30, 2021 | -19.00M |
| March 31, 2021 | -111.70M |
| December 31, 2020 | -0.057M |
| September 30, 2020 | -0.154M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.0623M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.0053M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.0594M |
| June 30, 2018 | -0.0315M |
| March 31, 2018 | -0.0051M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.0367M |
| September 30, 2017 | -0.1155M |
| June 30, 2017 | 18.86M |
| March 31, 2017 | 5.184M |
| December 31, 2016 | 0.4157M |
| September 30, 2016 | 3.373M |
| June 30, 2016 | -28.27M |
| March 31, 2016 | -0.352M |
| December 31, 2015 | -0.9765M |
| September 30, 2015 | -0.569M |
| June 30, 2015 | -0.4409M |
| March 31, 2015 | -0.2471M |
| December 31, 2014 | -0.0642M |
| September 30, 2014 | -0.102M |
| June 30, 2014 | -0.0152M |
| March 31, 2014 | -0.1185M |
| December 31, 2013 | -0.0782M |
| September 30, 2013 | -0.211M |
| June 30, 2013 | -0.2668M |
| March 31, 2013 | -0.0934M |
| December 31, 2012 | -0.0579M |
| September 30, 2012 | -0.0713M |
| June 30, 2012 | -0.043M |
| March 31, 2012 | -0.098M |
| December 31, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-111.70M
Minimum
Mar 2021
18.36M
Maximum
Mar 2022
-2.637M
Average
1.910M
Median
Cash from Investing (Quarterly) Benchmarks
| BioVie Inc | 0.00 |
| Perspective Therapeutics Inc | -0.089M |
| Biolase Inc | -0.003M |
| Tenon Medical Inc | -0.092M |
| Adial Pharmaceuticals Inc | 0.35M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.74M |
| Cash from Financing (Quarterly) | 0.107M |
| Free Cash Flow | -30.62M |
| Free Cash Flow Per Share (Quarterly) | -0.175 |
| Free Cash Flow to Equity (Quarterly) | -7.82M |
| Free Cash Flow Yield | -18.83% |